a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
Published 4 months ago • 91 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
2:36
andromeda: daratumumab cybord for al amyloidosis
-
1:45
a phase ii study of elritercept for lower-risk mds
-
1:03
real-world management of patients with al amyloidosis
-
4:30
andromeda: daratumumab for al amyloidosis
-
2:46
single use daratumumab for al amyloidosis
-
1:21
andromeda study: updated safety run-in results
-
3:08
real-world data on treatment strategies and outcomes in systemic al amyloidosis
-
1:45
real-world data in guiding amyloidosis treatment
-
46:05
cliff brangwynne (princeton & hhmi) 1: liquid phase separation in living cells
-
3:28:55
ai and causality: estimating heterogeneous treatment effects, interpretability and explainability
-
10:02
2 of 4 | sequencing on the aviti™ - unique chemistry
-
4:01
early diagnosis and optimal treatment of al amyloidosis
-
1:06
daratumumab and carfilzomib for al amyloid neuropathy
-
2:20
new prognostic markers in al amyloidosis
-
4:01
al amyloidosis: multidisciplinary treatment approach
-
0:51
insights into a phase i/ii study assessing golidocitinib in ptcl
-
3:13
the ultragenyx phase 2 and 3 orbit study
-
1:07:55
iddi webinar: design and analysis of phase ii trials in oncology
-
1:18
whitehead institute: phase condensation in transcription
-
0:16
mars view in telescope #shorts #space #nasa
-
41:14
management of al amyloidosis: an update
-
31:36
is whole exome sequencing (wes) the answer to end the diagnostic odyssey in rare diseases?